Patricia A. Martin

Executive

AN2 Therapeutics, Inc.Cypherpunk Technologies Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 1 saleOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€169k

Latest filing published 13 Oct 2026 for AN2 Therapeutics, Inc.. Read the official filing

Filing timeline

BuySale

Patricia A. Martin

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Patricia A. Martin: trading record in brief

This profile gathers the share dealings of Patricia A. Martin across 2 companies, led by AN2 Therapeutics, Inc. and Cypherpunk Technologies Inc. We count 10 filings; the first trade dates from 19 December 2024 and the latest from 12 October 2026.

The open-market record consists of 1 sale worth €169k, with no purchase. Outside the open market, there are 8 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.

On 13 October 2026 came the latest disclosure, a share grant in AN2 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.